The market studied is being driven by factors, such as an increase in the R&D funding, along with the increasing healthcare expenditure and technological advancements in the Laser Capture Microdissection (LCM).
According to the Office for National Statistics (ONS), the total R&D expenditure in the United Kingdom is increasing rapidly. During 2016, it was around GBP 33.2 billion, which increased in 2017 and reached around GBP 34.8 billion. Similarly, in the United States, the investments in medical R&D was USD 39.5 billion in 2017. This indicates that there is a high investment done in healthcare in the major countries.
Trends are showing a return to growth, with only minor caution, across most areas of R&D spending. The increase in R&D investment in Asia, particularly India, and the consecutive annual growth in R&D spending in the country, indicate a period of stability, security, and healthy competition across the industrial sectors. A national survey by the Central Government of India, on the status of R&D in the country, has shown that India’s Gross Expenditure on R&D (GERD) has more than tripled, from INR 241.17 billion (INR 24,117 crore) to INR 853.26 billion (INR 85,326 crore) during the decade, from 2004-2005 to 2014-2015.
Furthermore, it is indicated that the rising R&D investment will have a positive impact on the market studied and the market will grow rapidly over the forecast period.
Key Market Trends Diagnostics is Expected to Register a Highest CAGR Over the Forecast Period
Currently, microdissection of tissue sections and cytological preparations have been used increasingly for the isolation of homogeneous, morphologically identified cell populations, thus, overcoming the obstacle of tissue complexity. In conjunction with sensitive analytical techniques, such as the polymerase chain reaction, microdissection allows precise in vivo examination of cell populations, such as carcinoma in situ, or the malignant cells of Hodgkin’s disease, which are otherwise inaccessible for conventional molecular studies.
Laser Capture Microdissection (LCM) may allow the establishment of "genetic fingerprints" of specific pathological lesions, especially malignant neoplasms. In addition to the identification of new diagnostic and prognostic markers, this approach could help in establishing individualized treatment, tailored to the molecular profile of a tumor. Thus, the increased application of LCM in diagnostics is augmenting the growth of the market.
North America to Dominate the Market
Geographically, North America is dominating the global laser capture micro-dissection market, primairly due to the availability of skilled personnel. Also, due to robust healthcare infrastructure in the United States, which is coupled with extensive funding for medical research projects. This will continue to fuel the adoption of laser capture micro-dissection in North America. It has been observed that Asia-Pacific will be the fastest-growing market for laser capture microdissection, mainly due to the rising investment in healthcare R&D in Asian countries.
Competitive Landscape The laser capture microdissection market is moderately competitive and consists of the global, as well as local players. In countries, like India, there are several local players and these companies are holding a substantial share of the market. A similar scenario was observed in developed countries, such as the United States and a few European countries. With the rising focus on R&D, it is believed that more companies will enter the market in the coming future.
Reasons to Purchase this report: - The market estimate (ME) sheet in Excel format - 3 months of analyst support
Our reports have been used by over 10K customers, including:
Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Colorectal Cancer Diagnostic Tests pipeline products...
Retrovirus Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Retrovirus Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Retrovirus Tests pipeline products with comparative analysis of the products at various stages...
Bacteriology Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Bacteriology Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Bacteriology Rapid Tests & POC pipeline products with comparative...
Biobanking Market by Specimen Type (Blood Products, Solid Tissue, Nucleic Acid, and Cell Lines), Type of Biobank (Population-based Biobanks and Disease-oriented Biobanks), Ownership (National/Regional Agencies, Nonprofit Organization, University, and Private Organization), and Application (Therapeutic and Research): Global Opportunity...
Brain Biomarkers Market Research Report by Product (Biomarker Analyzers and Biomarker Test Kits), by Indication (Alzheimer’s disease & other dementias, Huntington’s disease, MND & ALS, Parkinson’s disease, and Stroke), by End-Users, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The...
Cancer Biomarkers Market Research Report by Biomolecule Type (Epigenetic, Genetic, Metabolic, and Proteomic), by Cancer Type (Blood Cancer, Breast Cancer, Colorectal Cancer, Lung Cancer, and Ovarian Cancer), by Technology, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The...
Diabetes Assays - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Diabetes Assays - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Diabetes Assays pipeline products with comparative analysis of the products at various stages...
Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Ovarian Cancer Diagnostic Tests pipeline products with comparative...
Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Pancreatic Cancer Diagnostic Tests pipeline products...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.